Braun Stacey Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,163
| Closed | -$1.59M | – | 117 |
|
|
2024
Q2 | $1.59M | Sell |
10,163
-23,751
| -70% | -$3.57M | 0.06% | 93 |
|
|
2024
Q1 | $4.59M | Sell |
33,914
-21,838
| -39% | -$2.89M | 0.18% | 89 |
|
|
2023
Q4 | $7.51M | Sell |
55,752
-14,295
| -20% | -$1.86M | 0.34% | 88 |
|
|
2023
Q3 | $9.49M | Sell |
70,047
-17,653
| -20% | -$2.41M | 0.46% | 84 |
|
|
2023
Q2 | $12.6M | Sell |
87,700
-75,439
| -46% | -$11.1M | 0.58% | 82 |
|
|
2023
Q1 | $22.6M | Buy |
163,139
+92,003
| +129% | +$12.4M | 0.59% | 84 |
|
|
2022
Q4 | $9.65M | Sell |
71,136
-12,393
| -15% | -$1.55M | 0.55% | 83 |
|
|
2022
Q3 | $9.16M | Sell |
83,529
-18,978
| -19% | -$2.41M | 0.56% | 84 |
|
|
2022
Q2 | $13.5M | Buy |
+102,507
| New | +$13.5M | 0.77% | 61 |
|
|
2017
Q1 | – | Sell |
-4,550
| Closed | -$249K | – | 142 |
|
|
2016
Q4 | $249K | Sell |
4,550
-2,000
| -31% | -$114K | 0.02% | 150 |
|
|
2016
Q3 | $430K | Hold |
6,550
| – | – | 0.03% | 129 |
|
|
2016
Q2 | $395K | Hold |
6,550
| – | – | 0.03% | 132 |
|
|
2016
Q1 | $369K | Hold |
6,550
| – | – | 0.02% | 136 |
|
|
2015
Q4 | $445K | Hold |
6,550
| – | – | 0.03% | 122 |
|
|
2015
Q3 | $417K | Sell |
6,550
-11,450
| -64% | -$753K | 0.03% | 122 |
|
|
2015
Q2 | $573K | Buy |
18,000
+10,400
| +137% | +$712K | 0.02% | 226 |
|
|
2015
Q1 | $520K | Buy |
7,600
+2,900
| +62% | +$201K | 0.03% | 115 |
|
|
2014
Q4 | $331K | Hold |
4,700
| – | – | 0.02% | 135 |
|
|
2014
Q3 | $336K | Sell |
4,700
-300
| -6% | -$22K | 0.02% | 133 |
|
|
2014
Q2 | $372K | Sell |
5,000
-1,000
| -17% | -$72.3K | 0.02% | 125 |
|
|
2014
Q1 | $389K | Hold |
6,000
| – | – | 0.02% | 121 |
|
|
2013
Q4 | $356K | Hold |
6,000
| – | – | 0.02% | 121 |
|
|
2013
Q3 | $312K | Hold |
6,000
| – | – | 0.02% | 123 |
|
|
2013
Q2 | $284K | Buy |
+6,000
| New | +$306K | 0.02% | 134 |
|